There were no statistically significant differences between the two groups of patients in terms of BMI, tumor location, tumor size, T stage, TNM stage, lymphatic invasion, cancer embolus, histological type, histological grade, ER positivity rate, PR positivity rate, HER2 positivity rate, and adjuvant therapy. This evidence concerns the gene ESR1 and neoplasm.